ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

No reported Cost of Revenue figures are available to summarize.

Cost of Revenue history

Currency unavailable · from the income statement

No Cost of Revenue data reported for this period type.

Cost of Revenue vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Cost of Revenue for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRMEPrime Medicine, Inc.LTM Mar 2026$47.71M USD——1182.7%
MGTXMeiraGTx Holdings plcLTM Mar 2026$6.67M USD-73.5%—8.4%
WVEWave Life Sciences Ltd.LTM Mar 2026$4.46M USD+106.0%—6.2%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$4M USD——8.8%
STOKStoke Therapeutics, Inc.LTM Mar 2026$3.09M USD+178.5%—9.6%
PRQRProQR Therapeutics N.V.LTM Mar 2026€1.38M EUR——10.3%
SLNSilence Therapeutics plcLTM Mar 2026$309.37K USD—-73.0%33.6%
BNTCBenitec Biopharma Inc.LTM Mar 2026$119K USD-36.4%——
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+34.8%-73.0%9.2%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.